RJT
WST icon

Raymond James Trust’s West Pharmaceutical WST Stock Holding History

Raymond James Trust’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$982K Buy
3,271
+389
+13% +$119K 0.02% 505
2024
Q2 		$949K Buy
2,882
+137
+5% +$48.4K 0.02% 486
2024
Q1 		$1.09M Sell
2,745
-124
-4% -$45.9K 0.03% 450
2023
Q4 		$1.01M Buy
2,869
+45
+2% +$15.9K 0.03% 454
2023
Q3 		$1.06M Sell
2,824
-55
-2% -$21.3K 0.03% 409
2023
Q2 		$1.1M Buy
2,879
+111
+4% +$39.7K 0.03% 408
2023
Q1 		$959K Buy
2,768
+508
+22% +$148K 0.03% 420
2022
Q4 		$532K Sell
2,260
-580
-20% -$137K 0.02% 575
2022
Q3 		$699K Buy
2,840
+86
+3% +$26.2K 0.03% 465
2022
Q2 		$833K Sell
2,754
-251
-8% -$81.7K 0.03% 423
2022
Q1 		$1.23M Buy
3,005
+90
+3% +$35.2K 0.04% 362
2021
Q4 		$1.37M Buy
2,915
+53
+2% +$22.8K 0.04% 349
2021
Q3 		$1.22M Buy
2,862
+149
+5% +$62.8K 0.04% 348
2021
Q2 		$974K Sell
2,713
-339
-11% -$112K 0.03% 410
2021
Q1 		$860K Buy
3,052
+1,954
+178% +$559K 0.03% 412
2020
Q4 		$311K Sell
1,098
-120
-10% -$33.7K 0.01% 760
2020
Q3 		$335K Buy
1,218
+337
+38% +$89.2K 0.01% 651
2020
Q2 		$200K Buy
+881
New +$173K 0.01% 847

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Trust's WST Position: Q3 2024 in Review

Raymond James Trust increased its West Pharmaceutical (WST) stake by 13% in Q3 2024, buying an estimated $119K and bringing the position to 3,271 shares worth $982K. The position accounts for 0.02% of the portfolio, ranked #505.

Raymond James Trust first reported a position in WST in Q2 2020 and has held it in 18 quarters since. The position peaked at $1.37M in Q4 2021. 729 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Raymond James Trust held 3,271 shares of West Pharmaceutical worth $982K as of Q3 2024.
  • Raymond James Trust bought 389 West Pharmaceutical shares in Q3 2024, an estimated $119K.
  • West Pharmaceutical made up 0.02% of Raymond James Trust's portfolio in Q3 2024, its #505 holding.
  • Raymond James Trust first reported a position in West Pharmaceutical in Q2 2020 and has held it in 18 quarters since.
  • Raymond James Trust's West Pharmaceutical position peaked at $1.37M in Q4 2021.
  • 729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.